RESUMEN
The present research was aimed to develop a terbinafin hydrochloride (TH)-encapsulated solid lipid nanoparticles (SLNs) hydrogel for improved antifungal efficacy. TH-loaded SLNs were obtained from glyceryl monostearate (lipid) and Pluronic® F68 (surfactant) employing high-pressure homogenization. The ratio of drug with respect to lipid was optimized, considering factors such as desired particle size and highest percent encapsulation efficiency. Lyophilized SLNs were then incorporated in the hydrogel prepared from 0.2-1.0% w/v carbopol 934P and further evaluated for rheological parameters. The z-average, zeta potential and polydispersity index were found to be 241.3 nm, -15.2 mV and 0.415, respectively. The SLNs show a higher entrapment efficiency of about 98.36%, with 2.12 to 6.3602% drug loading. SEM images, XRD and the results of the DSC, FTIR show successful preparation of SLNs after freeze drying. The TH-loaded SLNs hydrogel showed sustained drug release (95.47 ± 1.45%) over a period of 24 h. The results reported in this study show a significant effect on the zone of inhibition than the marketed formulation and pure drug in Candida albicans cultures, with better physical stability at cooler temperatures. It helped to enhance skin deposition inthe ex vivostudy and improved, in vitro and in vivo, the antifungal activity.
RESUMEN
Ethanol ingestion by a mother during pregnancy entails adverse consequences for her offspring. In this study, adult female rats were given access to ethanol from 8 days prior to mating to post-parturition weaning, and the effects on her offspring were evaluated. We investigated changes in the cocaine- and amphetamine-regulated transcript peptide (CART), a neuropeptide involved in the central effects of ethanol in the frame of reward and stress processing circuits. CART-immunoreactivity was augmented in the cells of Edinger-Westphal (EW) nucleus and lateral hypothalamus (LH) and fibers in the LH and ventral tegmental area (VTA) in 25-day-old pups. On the other hand, a significant decrease was seen in the expression of the peptide in paraventricular nucleus (PVN), arcuate nucleus (ARC), hippocampus (CA1 and CA2) and locus coeruleus (LC). The offspring at 85â¯days showed increased anxiety in elevated plus maze and immobility in forced swim test suggestive of depression. These rats also failed to discriminate between novel versus familiar object in object recognition test indicating memory deficits. Their brains showed decreased CART-immunoreactivity in nucleus accumbens shell, lateral bed nucleus of stria terminalis, PVN, ARC, LH, hippocampus and LC as compared to age-matched control offspring. However, CART-immunoreactive profile in EW and fibers in VTA of 85-day-old offspring was similar to that in the control. Thus, regional imbalance in the CART system of the offspring of alcoholic dams seems correlated with the affective and emotional abnormalities and memory deficits.
Asunto(s)
Ansiedad/metabolismo , Encéfalo/metabolismo , Depresión/metabolismo , Etanol/efectos adversos , Trastornos de la Memoria/metabolismo , Proteínas del Tejido Nervioso/biosíntesis , Efectos Tardíos de la Exposición Prenatal/metabolismo , Animales , Ansiedad/inducido químicamente , Encéfalo/efectos de los fármacos , Depresión/inducido químicamente , Etanol/administración & dosificación , Femenino , Masculino , Trastornos de la Memoria/inducido químicamente , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Ratas , Ratas Sprague-DawleyRESUMEN
Self-assembled nanocarriers (SANs) as a novel colloidal controlled delivery for docetaxel trihydrate (DTX) were engineered by high-pressure homogenization method to overcome the several clinical problems. Drug-excipient compatibility was studied using DSC and FTIR spectroscopy. The fabricated SANs was characterized by particle size, zeta potential, and SEM. QbD based central composite design of experiment was employed for formula optimization. The cell viability of DTX-hydroalcoholic solution (DTX-HA) and DTX-loaded SANs has been determined in MDA-MB-231 cell line by MTT assay. The stability study of selected SANs formulations were carried out at various storage conditions as per ICH guidelines. The summary of results obtained shows high drug content with higher entrapment efficiency (91.23⯱â¯3.41% w/w) of DTX-loaded SANs. It shows diffusion controlled release of DTX over the period of 12â¯h which is higher than DTX-HA solution, releases the DTX within 4â¯h. The MTT assay expressed lower cellular viability and improved cell inhibition leads to increase cytotoxicity of formulations towards cells. The stability study reveals stability of DTX-loaded SANs formulations at various storage conditions over a period of three months. The strong experimental evidence confirms the SANs as an effective approach to formulate the controlled delivery system of antineoplastics with improved stability.
Asunto(s)
Antineoplásicos/farmacología , Preparaciones de Acción Retardada/farmacología , Docetaxel/farmacología , Portadores de Fármacos/farmacología , Nanopartículas/química , Antineoplásicos/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Preparaciones de Acción Retardada/química , Docetaxel/química , Portadores de Fármacos/química , Composición de Medicamentos/métodos , Liberación de Fármacos , Estabilidad de Medicamentos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Análisis Factorial , Glicéridos/química , Humanos , Cinética , Nanopartículas/ultraestructura , Tamaño de la Partícula , Poloxámero/químicaRESUMEN
Although plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) protects against cerebral ischemia and spinal cord injury-induced oxidative stress and inflammation by activating the nuclear factor-erythroid 2-related factor-2 /antioxidant response element (Nrf2/ARE) pathway, its role in the amelioration of neurodegenerative diseases remains unexplored. In the present study, we investigated the effect of plumbagin on Alzheimer's disease (AD)-like condition in mice. The animals were treated intracerebroventricularly with streptozotocin (STZ; 3â¯mg/kg) twice, on day 1 and 3, to induce AD-like condition, and the symptoms were evaluated after 14 days. While the loss of learning and memory performance was evident in the mice subjected to Morris water maze (MWM), there was a striking increase in the population of astrocytes labelled with glial ï¬brillary acidic protein (GFAP) in the hippocampus. Daily intraperitoneal (i.p.) treatment with plumbagin (0.5 and 1â¯mg/kg), starting from 1â¯h prior to first dose of STZ, significantly prevented the cognitive deficits in MWM. On the other hand, administration of Nrf2/ARE pathway inhibitor, trigonelline (10 and 15â¯mg/kg, i.p.) enhanced the effects of STZ. Pre-treatment with subeffective dose of trigonelline (5â¯mg/kg) significantly attenuated the effects of plumbagin in MWM. While plumbagin prevented the STZ induced GFAP expression, this effect of plumbagin was attenuated by trigonelline. Moreover, the in silico docking study revealed potent inhibitory effect of plumbagin on ß-secretase enzyme. The results of the present study suggest that plumbagin improves cognitive function in STZ induced mouse model of AD possibly via Nrf2/ARE mediated suppression of astrogliosis and inhibition of ß-secretase enzyme.
Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Elementos de Respuesta Antioxidante/efectos de los fármacos , Memoria/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Naftoquinonas/farmacología , Enfermedad de Alzheimer/inducido químicamente , Enfermedad de Alzheimer/metabolismo , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/metabolismo , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/metabolismo , Modelos Animales de Enfermedad , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Estreptozocina/farmacologíaRESUMEN
Exaggerated thoughts, diminished mood and impaired cognition are the hallmarks of the schizophrenia-like condition. These symptoms are attributed to the dysregulation of dopamine and glutamate signaling in the brain. Since cocaine- and amphetamine-regulated transcript peptide (CART) modulates actions of dopamine as well as glutamate, we tested the role of this peptide in MK-801-induced schizophrenic dementia-like condition. MK-801-treated rats were allowed to interact with conspecific juvenile and tested for short-term (30-min) and long-term (24-h) social memory acquisition and recall. While MK-801 impaired the social interaction with a juvenile, the behavior was restored in CART [intracerebroventricular (icv) or intra-ventral tegmental area (VTA)] pre-treated animals. This action of CART was blocked by SCH23390 (dopamine D1 receptor antagonist) administered directly into the prefrontal cortex (PFC). Application of neuronal tracer Di-I in the PFC retrogradely labeled dopamine cells of the VTA, which in turn seem to receive CARTergic innervation. A significant increase in CARTimmunoreactivity was evidenced in the VTA, PFC and accumbens of the animals allowed to interact with a juvenile. However, MK-801 treatment attenuated the peptide expression and induced social memory deficits. The schizophrenic dementia-like symptoms following antagonism of glutamatergic receptors may be attributed to the reduced dopamine activity in the mesocortical system. We suggest that CART may, positively modulate the dopamine system to alleviate cognitive deficits associated with schizophrenia.
Asunto(s)
Demencia/tratamiento farmacológico , Proteínas del Tejido Nervioso/farmacología , Psicotrópicos/farmacología , Esquizofrenia/tratamiento farmacológico , Animales , Benzazepinas/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Demencia/metabolismo , Demencia/patología , Modelos Animales de Enfermedad , Maleato de Dizocilpina , Masculino , Memoria/efectos de los fármacos , Memoria/fisiología , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Proteínas del Tejido Nervioso/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/patología , Distribución Aleatoria , Ratas Wistar , Receptores de Dopamina D1/antagonistas & inhibidores , Receptores de Dopamina D1/metabolismo , Esquizofrenia/metabolismo , Esquizofrenia/patología , Psicología del Esquizofrénico , Conducta SocialRESUMEN
Although cocaine- and amphetamine-regulated transcript peptide (CART) is detected in several cortical and subcortical areas, its role in higher functions has been largely ignored. We examined the significance of CART in memory formation and tested if the downstream actions of CART involve N-methyl-d-aspartate (NMDA) activated extra-cellular signal-regulated kinase (ERK). Newly formed memory was evaluated using novel object recognition test consisting of familiarization (T1) and choice trials (T2). The choice trials were performed at two time points: 30-min (T230-min ) and 24-h (T224-h ) postacquisition. In choice trial (T230-min ), vehicle control rats explored the novel object for significantly longer duration than the familiar object indicating intact memory formation. However, CART-antibody, U0126 [ERK antagonist, both via intracerebroventricular (icv) or intrahippocampal (ih) route] or MK-801 (NMDA antagonist; intraperitoneal) treated rats spent less time exploring novel objects; CART peptide (icv or ih) was ineffective. During choice trial at T224-h , a significant decrease in novel object exploration time was noticed in vehicle control rats suggesting amnesia. However, treatment with CART, prior to familiarization trial (T1), promoted exploration of the novel object even at T224-h . Pretreatment with U0126 or MK-801 blocked pro-cognitive-like effect of CART suggesting involvement of NMDA-ERK pathway in CART's action. Animals subjected to the object familiarization trial showed a drastic increase in the CART-immunoreactivity in the cells of cornu ammonis 3 and polymorph layer of dentate gyrus, and fibers within ento- (ENT) and peri-rhinal (PRH) cortices. Western blot analysis revealed that CART treatment significantly up-regulated the expression of phospo-ERK1/2 in hippocampus, ENT and PRH. This effect was attenuated following pretreatment with U0126 or MK-801, suggesting the activation of ERK signaling cascade through NMDA receptors. Thus, CART system seems to play an important role in recognition memory and that these effects may be mediated by NMDA receptors-ERK signaling in the ENT/PRH-hippocampal circuit. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Hipocampo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Reconocimiento en Psicología/fisiología , Animales , Butadienos/farmacología , Conducta de Elección/efectos de los fármacos , Conducta de Elección/fisiología , Cognición/efectos de los fármacos , Cognición/fisiología , Maleato de Dizocilpina/farmacología , Corteza Entorrinal/efectos de los fármacos , Corteza Entorrinal/metabolismo , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Quinasas MAP Reguladas por Señal Extracelular/antagonistas & inhibidores , Hipocampo/efectos de los fármacos , Aprendizaje/efectos de los fármacos , Aprendizaje/fisiología , Masculino , Proteínas del Tejido Nervioso/administración & dosificación , Neuronas/efectos de los fármacos , Neuronas/fisiología , Pruebas Neuropsicológicas , Nitrilos/farmacología , Corteza Perirrinal/efectos de los fármacos , Corteza Perirrinal/metabolismo , Psicotrópicos/farmacología , Ratas Wistar , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Receptores de N-Metil-D-Aspartato/metabolismo , Reconocimiento en Psicología/efectos de los fármacosRESUMEN
Depression is a major comorbidity factor of diabetes and the outcome of one disorder influences the other. Our aim is to scrutinize the link between the two, if any. Since neuropeptide Y (NPY) system plays an important role in regulating central glucose sensing mechanisms, and also depression-related behavior, we test the involvement of NPY in the modulation of depression in type 2 diabetic mice. The mice were fed on high-fat diet and administered with low dose of streptozotocin to induce type 2 diabetes. These animals showed augmented plasma glucose and increased immobility time in tail suspension test (TST) suggesting induction of diabetes and depression. Intracerebroventricular (icv) treatment with NPY or NPY Y1 receptor agonist [Leu(31), Pro(34)]-NPY and intraperitoneal treatment with imipramine decreased immobility time. However, opposite effect was produced by NPY Y1 receptor antagonist BIBP3226 (icv). Moreover, reduced immobility time by imipramine was potentiated by NPY and [Leu(31), Pro(34)]-NPY, but attenuated by BIBP3226. Immunohistochemical analysis of the different nuclei of the extended amygdala, the region primarily involved in affective disorders, was undertaken. A significant reduction in NPY immunoreactivity in the central nucleus of amygdala, nucleus accumbens shell and lateral division of bed nucleus of stria terminalis of the diabetic mice was noticed; the response was ameliorated in imipramine treated animals. The results suggest that decreased NPY expression in the extended amygdala might be causally linked with the depression induced following type 2 diabetes and that the antidepressant action of imipramine in diabetic mice might be mediated by NPY-NPY Y1 receptor system.
Asunto(s)
Antidepresivos Tricíclicos/administración & dosificación , Depresión/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Imipramina/administración & dosificación , Neuropéptido Y/fisiología , Animales , Arginina/administración & dosificación , Arginina/análogos & derivados , Glucemia/metabolismo , Núcleo Amigdalino Central/metabolismo , Depresión/complicaciones , Depresión/prevención & control , Diabetes Mellitus Tipo 2/complicaciones , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Neuropéptido Y/administración & dosificación , Neuropéptido Y/metabolismo , Núcleo Accumbens/metabolismo , Receptores de Neuropéptido Y/agonistas , Receptores de Neuropéptido Y/antagonistas & inhibidores , Receptores de Neuropéptido Y/fisiología , Núcleos Septales/metabolismo , EstreptozocinaRESUMEN
Binge eating (BE) disrupts feeding and subverts reward mechanism. Since cocaine- and amphetamine-regulated transcript peptide (CART) mediates satiety as well as reward, its role in BE justifies investigation. To induce BE, rats were provided restricted access to high fat sweet palatable diet (HFSPD) for a period of 4 weeks. Immunoreactivity profile of the CART elements, and accompanying neuroplastic changes were studied in satiety- and reward-regulating brain nuclei. Further, we investigated the effects of CART, CART-antibody or rimonabant on the intake of normal chow or HFSPD. Rats fed on HFSPD showed development of BE-like phenotype as reflected by significant consumption of HFSPD in short time frame, suggestive of dysregulated satiety mechanisms. At the mid-point during BE, CART-immunoreactivity was significantly increased in hypothalamic arcuate (ARC), lateral (LH), nucleus accumbens shell (AcbSh) and paraventricular nucleus of thalamus (PVT). However, for next 22-h post-binge time-period, the animals showed no interest in food, and low CART expression. Pre-binge treatment with rimonabant, a drug recommended for the treatment of BE, produced anorexia, increased CART expression in ARC and LH, but not in AcbSh and PVT. Higher dose of CART was required to produce anorexia in binged rats. While neuronal tracing studies confirmed CART fiber connectivity from ARC and LH to AcbSh, increase in CART and synaptophysin immunostaining in this pathway in BE rats suggested strengthening of the CART connectivity. We conclude that CART bearing ARC-LH-PVT-AcbSh reward circuit may override the satiety signaling in ARC-PVN pathway in BE rats.
Asunto(s)
Trastorno por Atracón/metabolismo , Encéfalo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Anhedonia/efectos de los fármacos , Anhedonia/fisiología , Animales , Trastorno por Atracón/tratamiento farmacológico , Trastorno por Atracón/patología , Encéfalo/efectos de los fármacos , Encéfalo/patología , Antagonistas de Receptores de Cannabinoides/farmacología , Modelos Animales de Enfermedad , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Masculino , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Vías Nerviosas/patología , Piperidinas/farmacología , Pirazoles/farmacología , Distribución Aleatoria , Ratas Wistar , Recompensa , Rimonabant , Saciedad/efectos de los fármacos , Saciedad/fisiología , Sinaptofisina/metabolismoRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: Chenopodium album L. (C. album) is commonly known as Bathua in Hindi (Family: Chenopodiaceae). Traditionally, the plant is used as a laxative, diuretic, sedative and the infusion of the plant is used for the treatment of rheumatism. However, no scientific validation is available on the antirheumatic potential of the plant. In the present investigation, role of NF kappa B (NFκB) in the antiarthritic potential of extracts of aerial parts of Chenopodium album was explored and evaluated. METHODS: The defatted aerial parts of Chenopodium album were successively extracted with ethylacetate, acetone, methanol and 50% methanol to study their antioxidant capacity followed by antiarthritic potential using Complete Freund׳s adjuvant (CFA) induced arthritis model in rats. The polyphenol, flavonoid and flavanone contents of different extracts were quantified and correlated with their antioxidant capacity, antiarthritic activity and NFκB inhibition potential. RESULTS: The experimental data indicated that the acetone extract of Chenopodium album (ACCA) has shown significant reduction in rat paw edema (80.13%) at dose level of 200 mg/kg per oral in 21 days of this study. On 22nd day, hematological and biochemical parameters were estimated and it was observed that the altered hematological parameters (Hb, RBC, WBC and ESR), biochemical parameters (Serum creatinine, total proteins and acute phase proteins) and loss in body weight in the arthritic rats were significantly brought back to near normal level by the ACCA extract. ACCA extract significantly decreased the NFκB expression in paraventricular nucleus of hypothalamus and this effect is comparable with standard indomethacine in CFA treated rats. The polyphenolic and flavonoid content of different extracts were in the range of 14.56±0.21-42.00±0.2 mg (gallic acid equivalent/g extract) and 2.20±0.003-7.33±0.5 mg (rutin equivalent/g extract) respectively. CONCLUSION: The antiarthritic activity possessed by ACCA extract can be correlated directly to its antioxidant potential, high flavonoidal content achieved by successive extraction and its capacity to inhibit the NFκB protein, as proven by immunohistochemistry study.
Asunto(s)
Antirreumáticos/farmacología , Artritis Experimental/tratamiento farmacológico , Chenopodium album/química , FN-kappa B/metabolismo , Extractos Vegetales/farmacología , Animales , Antioxidantes/aislamiento & purificación , Antioxidantes/farmacología , Antirreumáticos/aislamiento & purificación , Artritis Experimental/patología , Flavanonas/química , Flavanonas/aislamiento & purificación , Flavanonas/farmacología , Flavonoides/química , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Indometacina/farmacología , Masculino , Componentes Aéreos de las Plantas , Polifenoles/química , Polifenoles/aislamiento & purificación , Polifenoles/farmacología , Ratas , Ratas WistarRESUMEN
INTRODUCTION: Intracranial self-stimulation (ICSS) is an operant paradigm in which rodents self-administer rewarding electrical stimulation through electrodes implanted into the brain. We describe a simple, inexpensive and reliable method to fabricate monopolar and bipolar electrodes, along with the swivel system, for delivery of electric pulses at the targeted sites in the brain of rat. METHODS: The system consists of an insulated stainless steel wire(s) (diameter: 0.25 mm), plastic base, pedestal and connector attached to a swivel via a stimulating cable, which is connected to the stimulator. We provide the specifications, source of each component, and the method of fabrication in details. RESULTS: In-house fabricated monopolar or bipolar electrodes were subjected to rigorous tests. We implanted the electrode into the medial forebrain bundle (MFB) and rat was trained to press the lever for electrical self-stimulation in operant chamber for 60 min each day. In about 3-4 days, the animal gave a consistent response (~40 presses/min) and was considered as conditioned. For evaluation of reinforcement behavior, the number of lever pressings of conditioned rat with or without electrical stimulation was assessed for a period of 30 min each day for 10 weeks. The rewarding frequency sustained for the entire duration. In addition, we compared the lever pressing data of the groups of rats implanted with in-house fabricated versus with those with commercial electrodes; no significant differences were encountered. DISCUSSION: The required components for the electrode fabrication are easily available. With some practice, the system can be easily assembled in the laboratory and costs less than a dollar. We suggest that the electrodes, fabricated using this method, may serve as an economical and reliable tool in neuropharmacological and neurobehavioral studies.
Asunto(s)
Encéfalo/fisiología , Electrodos Implantados/economía , Autoestimulación , Animales , Estimulación Eléctrica , Masculino , Ratas , Ratas Sprague-Dawley , RecompensaRESUMEN
In the present study, modulation of anxiolytic action of agmatine by neuropeptide Y (NPY) in the central nucleus of amygdala (CeA) is evaluated employing Vogel's conflict test (VCT) in rats. The intra-CeA administration of agmatine (0.6 and 1.2µmol/rat), NPY (10 and 20pmol/rat) or NPY Y1/Y5 receptors agonist [Leu(31), Pro(34)]-NPY (30 and 60pmol/rat) significantly increased the number of punished drinking licks following 15min of treatment. Combination treatment of subeffective dose of NPY (5pmol/rat) or [Leu(31), Pro(34)]-NPY (15pmol/rat) and agmatine (0.3µmol/rat) produced synergistic anxiolytic-like effect. However, intra-CeA administration of selective NPY Y1 receptor antagonist, BIBP3226 (0.25 and 0.5mmol/rat) produced anxiogenic effect. In separate set of experiment, pretreatment with BIBP3226 (0.12mmol/rat) reversed the anxiolytic effect of agmatine (0.6µmol/rat). Furthermore, we evaluated the effect of intraperitoneal injection of agmatine (40mg/kg) on NPY-immunoreactivity in the nucleus accumbens shell (AcbSh), lateral part of bed nucleus of stria terminalis (BNSTl) and CeA. While agmatine treatment significantly decreased the fibers density in BNSTl, increase was noticed in AcbSh. In addition, agmatine reduced NPY-immunoreactive cells in the AcbSh and CeA. Immunohistochemical data suggest the enhanced transmission of NPY from the AcbSh and CeA. Taken together, this study suggests that agmatine produced anxiolytic effect which might be regulated via modulation of NPYergic system particularly in the CeA.
Asunto(s)
Agmatina/farmacología , Ansiolíticos/farmacología , Ansiedad/tratamiento farmacológico , Núcleo Amigdalino Central/efectos de los fármacos , Neuropéptido Y/metabolismo , Animales , Ansiedad/patología , Ansiedad/fisiopatología , Arginina/análogos & derivados , Arginina/farmacología , Recuento de Células , Núcleo Amigdalino Central/patología , Núcleo Amigdalino Central/fisiopatología , Inmunohistoquímica , Masculino , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Neuropéptido Y/análogos & derivados , Neuropéptido Y/farmacología , Pruebas Neuropsicológicas , Núcleo Accumbens/efectos de los fármacos , Núcleo Accumbens/patología , Núcleo Accumbens/fisiopatología , Fotomicrografía , Ratas Sprague-Dawley , Receptores de Neuropéptido Y/antagonistas & inhibidores , Receptores de Neuropéptido Y/metabolismo , Núcleos Septales/efectos de los fármacos , Núcleos Septales/patología , Núcleos Septales/fisiopatologíaRESUMEN
Allopregnanolone (ALLO), a gamma-aminobutyric acid (GABA) type A receptor active neurosteroid, elicits hyperphagic response in rodents. Since GABA-A receptors are present on the peptidergic neurons in the hypothalamus, we were interested in finding out if ALLO and neuropeptide cocaine- and amphetamine-regulated transcript (CART) interact and influence feeding behavior. While subcutaneous ALLO treatment, for a period of 7 days, produced a significant increase in food intake and body weight, pretreatment with subthreshold dose of CART (intracerebroventricular) attenuated both the effects. On the other hand, subcutaneous administration of dehydroepiandrosterone sulfate (DHEAS; GABA-A inhibitor neurosteroid) for a period of 7 days resulted in a significant reduction in food intake and body weight. These effects of DHEAS were potentiated by intracerebroventricular pretreatment with subeffective dose of CART. The brains of ALLO-treated rats were processed for the immunohistochemical analysis of CART immunoreactive elements. ALLO treatment resulted in a significant reduction in CART immunoreactivity in the hypothalamic arcuate, paraventricular and lateral nuclei, and nucleus accumbens shell. The results of the present study suggest that ALLO and CART might interact in the brain, and influence food intake and body weight. However, further investigations are needed to clarify the precise mechanisms by which ALLO modulate feeding behavior.
Asunto(s)
Ingestión de Alimentos/efectos de los fármacos , Proteínas del Tejido Nervioso/metabolismo , Proteínas del Tejido Nervioso/farmacología , Pregnanolona/farmacología , Aumento de Peso/efectos de los fármacos , Animales , Hiperfagia/inducido químicamente , Hipotálamo/metabolismo , Masculino , Proteínas del Tejido Nervioso/efectos de los fármacos , Núcleo Accumbens/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
We explored the effect of cocaine- and amphetamine-regulated transcript peptide (CART), alone and in combination with methylprednisolone (MP), on the cellular pathology and locomotor recovery of mice following spinal cord injury (SCI). While cellular pathology was evaluated in terms of spinal cord histology and profile of astrocytes following immunolabeling with antibodies against glial fibrillary acidic protein (GFAP), locomotor recovery was monitored using hindlimb motor function scoring system. At 24 h post-SCI, there was a massive loss of motor function and cysts formation in the spinal cord. The SCI mice, following 3 days and onwards, showed a significant (P < 0.001) increase in the population and hypertrophy of GFAP + astrocytes, suggesting the occurrence of reactive astrogliosis. Intra-fourth ventricular administration of CART (54-102) or intravenous treatment with MP, dose dependently improved motor function score, while CART-antibody (intra-fourth ventricular) was ineffective. This neuroprotective effect of MP was potentiated by the subeffective dose of CART and antagonized by CART-antibody. CART or MP treatment not only prevented the cysts formation, but also significantly attenuated the population of GFAP + astrocytes at days 3, 7, 14, 21 and 28 post-SCI and the hypertrophy of astrocytes at day 14 and 28. The histological consequence of SCI, like cysts formation in the spinal cord, was rapidly improved by CART and/or MP. Taken together, the data suggest that CART may exert its neuroprotective effect via inhibition of post-SCI astrogliosis and participate in the MP mediated neuroprotection.
Asunto(s)
Gliosis/prevención & control , Proteínas del Tejido Nervioso/administración & dosificación , Fármacos Neuroprotectores/administración & dosificación , Neurotransmisores/administración & dosificación , Traumatismos de la Médula Espinal/prevención & control , Traumatismos de la Médula Espinal/fisiopatología , Animales , Gliosis/patología , Gliosis/fisiopatología , Inyecciones Intraventriculares , Masculino , Metilprednisolona/administración & dosificación , Ratones , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Destreza Motora/efectos de los fármacos , Destreza Motora/fisiología , Traumatismos de la Médula Espinal/patologíaRESUMEN
The present study underscores the effect of serotonergic antagonist on alpha-melanocyte stimulating hormone (α-MSH) induced neuronal regeneration. Swiss-albino mice were subjected to experimental spinal cord injury (ESCI) and treated with serotonergic antagonist, ritanserin, alone or in combination with α-MSH, and the locomotor recovery was investigated. ESCI was induced at thoracic T(10-12) level by compression method. Motor function score (0-10) of each mouse was monitored prior to, and on days 1, 4, 7, 10 and 14 following ESCI. Untreated ESCI animals showed almost normal hind limb motor function by 14days. Similar degree of recovery was observed on day 10 in animals given α-MSH or ritanserin. However, in animals treated with both agents, comparable recovery was observed on day 4. While histological examination of the spinal cord following ESCI showed demyelination, necrosis and cyst formation, treatment with ritanserin, alone and in combination with α-MSH, significantly prevented the tissue damage. We suggest that early antagonism of serotonergic 5-HT(2a/2c) receptors may potentiate the neurotropic and locomotor recovery activity of α-MSH.